Manhattan Associates (MANH) Financials

$183.41 +4.78 (+2.68%)

Closing price 05/2/2025 04:00 PM Eastern

Extended Trading

$180.86 -2.56 (-1.39%)

As of 05/2/2025 07:22 PM Eastern

Annual Income Statements for Manhattan Associates

This table shows Manhattan Associates' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	103	124	116	105	86	87	110	129	177	218
Consolidated Net Income / (Loss)	103	124	116	105	86	87	110	129	177	218
Net Income / (Loss) Continuing Operations	103	124	116	105	86	87	110	129	177	218
Total Pre-Tax Income	163	196	185	136	116	114	134	158	214	267
Total Operating Income	161	194	186	134	116	114	134	153	210	262
Total Gross Profit	321	355	349	318	333	586	366	409	498	571
Total Revenue	556	605	595	559	618	586	664	767	929	1,042
Operating Revenue	556	605	595	559	618	586	664	767	929	1,042
Total Cost of Revenue	235	250	246	241	285	0.00	298	358	431	471
Operating Cost of Revenue	235	250	246	241	285	-	298	358	431	471
Total Operating Expenses	159	160	163	184	217	472	231	256	288	310
Selling, General & Admin Expense	49	48	46	-	65	61	68	73	81	90
Marketing Expense	49	48	47	51	57	48	58	65	74	76
Research & Development Expense	54	55	58	72	88	84	98	112	127	138
Depreciation Expense	7.76	9.09	9.06	8.61	7.99	8.95	7.91	6.66	5.75	6.30
Total Other Income / (Expense), net	1.40	1.80	-0.81	2.34	0.15	-0.29	-0.26	5.42	3.79	5.22
Interest Expense	-1.33	-1.16	-1.17	-1.07	-0.72	-0.10	-0.07	-0.60	-5.30	-6.03
Other Income / (Expense), net	0.06	0.64	-1.99	1.28	-0.56	-0.38	-0.33	4.83	-1.51	-0.81
Income Tax Expense	59	72	68	32	30	27	24	29	37	48
Basic Earnings per Share	$1.41	$1.73	$1.68	$1.58	$1.33	$1.37	$1.74	$2.05	$2.86	$3.56
Weighted Average Basic Shares Outstanding	73.44M	71.67M	69.18M	66.20M	64.40M	63.54M	63.45M	62.77M	61.82M	61.30M
Diluted Earnings per Share	$1.40	$1.72	$1.68	$1.58	$1.32	$1.36	$1.72	$2.03	$2.82	$3.51
Weighted Average Diluted Shares Outstanding	74.04M	72.06M	69.42M	66.43M	65.10M	64.33M	64.32M	63.41M	62.61M	62.18M
Weighted Average Basic & Diluted Shares Outstanding	73.40M	71.80M	69.30M	66.30M	63.77M	63.80M	63.15M	62.50M	-	61.12M

This table shows Manhattan Associates' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	30	38	39	40	49	49	54	53	64	48	53
Consolidated Net Income / (Loss)	30	38	39	40	49	49	54	53	64	48	53
Net Income / (Loss) Continuing Operations	30	38	39	40	49	49	54	53	64	48	53
Total Pre-Tax Income	38	46	47	52	55	60	59	69	76	63	65
Total Operating Income	37	45	47	50	53	59	58	68	75	61	63
Total Gross Profit	102	108	117	122	127	132	255	145	148	24	148
Total Revenue	198	198	221	231	238	238	255	265	267	256	263
Operating Revenue	198	198	221	231	238	238	255	265	267	256	263
Total Cost of Revenue	96	90	104	109	111	107	0.00	120	119	232	115
Operating Cost of Revenue	96	90	104	109	111	107	-	120	119	-	115
Total Operating Expenses	65	63	70	72	74	73	197	77	73	-37	85
Selling, General & Admin Expense	18	18	20	20	21	20	21	21	20	27	24
Marketing Expense	16	17	18	19	18	20	20	19	17	20	21
Research & Development Expense	29	27	31	32	33	31	35	35	34	33	35
Depreciation Expense	1.66	1.51	1.49	1.32	1.44	1.51	1.49	1.49	1.69	1.63	1.54
Restructuring Charge	-	-	-	-	-	-	-	-	-	-	2.93
Total Other Income / (Expense), net	1.61	0.83	0.14	1.04	1.74	0.87	1.00	0.91	1.31	2.00	1.34
Other Income / (Expense), net	1.61	0.23	0.14	1.04	1.74	-4.44	1.00	0.91	1.31	-4.03	1.34
Income Tax Expense	8.71	7.67	8.44	12	5.77	11	4.83	16	13	15	12
Basic Earnings per Share	$0.47	$0.61	$0.62	$0.64	$0.80	$0.80	$0.87	$0.86	$1.04	$0.79	$0.86
Weighted Average Basic Shares Outstanding	62.59M	62.77M	62.21M	61.86M	61.64M	61.82M	61.63M	61.42M	61.17M	61.30M	60.87M
Diluted Earnings per Share	$0.47	$0.59	$0.62	$0.63	$0.79	$0.78	$0.86	$0.85	$1.03	$0.77	$0.85
Weighted Average Diluted Shares Outstanding	63.17M	63.41M	62.77M	62.43M	62.31M	62.61M	62.49M	62.12M	61.95M	62.18M	61.53M
Weighted Average Basic & Diluted Shares Outstanding	62.40M	62.50M	62.03M	61.67M	61.57M	0.00	61.57M	61.25M	61.08M	61.12M	60.71M

This table details how cash moves in and out of Manhattan Associates' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	2.71	-23	27	-22	12	94	59	-38	45	-4.51
Net Cash From Operating Activities	120	139	164	137	147	141	185	180	246	295
Net Cash From Continuing Operating Activities	120	139	164	137	147	141	185	180	246	295
Net Income / (Loss) Continuing Operations	103	124	116	105	86	87	110	129	177	218
Consolidated Net Income / (Loss)	103	124	116	105	86	87	110	129	177	218
Depreciation Expense	7.76	9.09	9.06	8.61	7.99	8.95	7.91	6.66	5.75	6.30
Non-Cash Adjustments To Reconcile Net Income	15	11	30	20	31	52	83	58	73	93
Changes in Operating Assets and Liabilities, net	-5.66	-5.39	8.90	3.83	22	-7.74	-17	-14	-9.01	-22
Net Cash From Investing Activities	-14	3.36	-5.77	-9.84	-14	-2.73	-4.02	-6.59	-4.73	-8.68
Net Cash From Continuing Investing Activities	-14	3.36	-5.77	-9.84	-14	-2.73	-4.02	-6.59	-4.73	-8.68
Purchase of Property, Plant & Equipment	-11	-6.84	-6.20	-7.31	-15	-2.73	-4.02	-6.59	-4.73	-8.68
Purchase of Investments	-15	-	-13	-15	-	0.00	0.00	0.00	0.00	0.00
Net Cash From Financing Activities	-102	-163	-132	-149	-121	-44	-120	-204	-196	-286
Net Cash From Continuing Financing Activities	-102	-163	-132	-149	-121	-44	-120	-204	-196	-286
Repurchase of Common Equity	-112	-168	-132	-149	-121	-44	-120	-204	-196	-286
Other Net Changes in Cash	-	-	-	-	-	-	-	-6.83	-0.16	-4.47
Cash Income Taxes Paid	51	59	65	40	30	24	29	58	67	83

This table details how cash moves in and out of Manhattan Associates' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	-17	28	-44	-28	29	88	-63	-4.82	12	51	-60
Net Cash From Operating Activities	40	55	59	41	59	88	55	73	62	105	75
Net Cash From Continuing Operating Activities	44	55	59	41	59	88	55	73	62	105	75
Net Income / (Loss) Continuing Operations	30	38	39	40	49	49	54	53	64	48	53
Consolidated Net Income / (Loss)	30	38	39	40	49	49	54	53	64	48	53
Depreciation Expense	1.66	1.51	1.49	1.32	1.44	1.51	1.49	1.49	1.69	1.63	1.54
Non-Cash Adjustments To Reconcile Net Income	18	17	18	18	18	18	22	25	24	21	30
Changes in Operating Assets and Liabilities, net	-5.18	-0.64	0.62	-19	-11	20	-23	-5.78	-27	34	-8.37
Net Cash From Investing Activities	-1.91	-2.44	-0.67	-1.01	-1.09	-1.97	-2.32	-2.22	-1.01	-3.13	-0.89
Net Cash From Continuing Investing Activities	-1.91	-2.44	-0.67	-1.01	-1.09	-1.97	-2.32	-2.22	-1.01	-3.13	-0.89
Purchase of Property, Plant & Equipment	-1.91	-2.44	-0.67	-1.01	-1.09	-1.97	-2.32	-2.22	-1.01	-3.13	-0.89
Net Cash From Financing Activities	-51	-25	-102	-67	-27	-0.33	-114	-76	-52	-45	-136
Net Cash From Continuing Financing Activities	-51	-25	-102	-67	-27	-0.33	-114	-76	-52	-45	-136
Repurchase of Common Equity	-51	-25	-102	-67	-27	-0.33	-114	-76	-52	-45	-136
Other Net Changes in Cash	-	-	-0.23	-0.44	-1.87	2.37	-1.80	-0.15	2.56	-5.08	1.72

This table presents Manhattan Associates' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	332	297	315	307	372	465	540	570	673	758
Total Current Assets	237	207	228	215	232	334	408	415	479	503
Cash & Equivalents	118	96	126	99	111	205	264	225	271	266
Accounts Receivable	97	100	92	100	101	109	124	167	181	205
Prepaid Expenses	9.22	10	9.15	11	14	15	17	23	21	22
Current Deferred & Refundable Income Taxes	-	-	-	0.77	1.33	1.87	2.60	-	1.37	5.19
Other Current Assets	1.55	0.94	1.17	2.77	4.94	3.54	0.64	-	5.20	4.14
Plant, Property, & Equipment, net	21	17	15	14	23	18	14	13	12	14
Total Noncurrent Assets	74	73	71	77	118	113	117	142	182	240
Goodwill	62	62	62	62	62	62	62	62	62	62
Noncurrent Deferred & Refundable Income Taxes	4.65	2.87	1.88	5.44	6.81	5.76	7.65	37	66	95
Other Noncurrent Operating Assets	7.28	7.60	7.30	9.77	48	45	48	43	54	84
Total Liabilities & Shareholders' Equity	332	297	315	307	372	465	540	570	673	758
Total Liabilities	137	128	140	160	230	247	289	343	395	458
Total Current Liabilities	127	118	124	145	182	197	249	316	366	400
Accounts Payable	11	12	14	18	21	18	20	26	25	27
Accrued Expenses	14	13	12	12	19	21	23	25	27	22
Current Deferred Revenue	69	63	-	-	94	-	153	209	238	278
Current Deferred & Payable Income Tax Liabilities	4.07	8.92	7.23	3.54	1.35	1.87	0.38	2.05	3.03	1.26
Current Employee Benefit Liabilities	29	21	16	29	46	42	53	54	73	72
Total Noncurrent Liabilities	9.57	10	16	15	48	50	40	28	29	58
Other Noncurrent Operating Liabilities	5.72	7.15	14	15	48	50	40	28	29	58
Commitments & Contingencies	-	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Total Equity & Noncontrolling Interests	195	169	175	147	142	219	251	227	278	299
Total Preferred & Common Equity	195	169	175	147	142	219	251	227	278	299
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	195	169	175	147	142	219	251	227	278	299
Common Stock	0.73	0.70	0.68	0.65	0.64	0.64	0.63	0.62	0.62	0.61
Retained Earnings	207	185	186	163	159	237	270	254	305	329
Accumulated Other Comprehensive Income / (Loss)	-12	-16	-12	-17	-18	-18	-20	-28	-27	-31

This table presents Manhattan Associates' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	515	531	527	573	675	665	698	708
Total Current Assets	367	372	360	393	445	426	452	455
Cash & Equivalents	197	182	153	182	208	203	215	206
Accounts Receivable	144	161	178	183	206	191	200	211
Prepaid Expenses	26	29	28	27	32	32	38	39
Plant, Property, & Equipment, net	12	12	12	11	13	13	13	14
Total Noncurrent Assets	136	147	155	169	217	226	233	239
Goodwill	62	62	62	62	62	62	62	62
Noncurrent Deferred & Refundable Income Taxes	28	40	48	56	70	79	87	92
Other Noncurrent Operating Assets	45	45	45	51	85	85	84	85
Total Liabilities & Shareholders' Equity	515	531	527	573	675	665	698	708
Total Liabilities	317	350	356	363	435	425	420	463
Total Current Liabilities	284	323	331	333	372	363	362	405
Accounts Payable	27	25	26	25	26	26	23	24
Accrued Expenses	-	24	25	26	25	23	23	26
Current Deferred Revenue	169	216	227	213	264	259	253	297
Current Deferred & Payable Income Tax Liabilities	2.15	11	0.11	0.52	8.28	0.43	0.29	3.39
Current Employee Benefit Liabilities	63	46	52	67	49	55	63	55
Total Noncurrent Liabilities	33	27	26	30	63	62	58	58
Other Noncurrent Operating Liabilities	33	27	26	30	63	62	58	58
Total Equity & Noncontrolling Interests	198	181	171	210	240	241	278	245
Total Preferred & Common Equity	198	181	171	210	240	241	278	245
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	198	181	171	210	240	241	278	245
Common Stock	0.62	0.62	0.62	0.62	0.62	0.61	0.61	0.61
Retained Earnings	226	207	197	238	267	268	303	274
Accumulated Other Comprehensive Income / (Loss)	-29	-27	-27	-29	-28	-28	-26	-30

This table displays calculated financial ratios and metrics derived from Manhattan Associates' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	13.06%	8.66%	-1.65%	-5.96%	10.51%	-5.11%	13.18%	15.59%	21.07%	12.23%
EBITDA Growth	27.17%	20.54%	-5.55%	-25.40%	-14.21%	-0.59%	15.73%	15.69%	30.41%	24.74%
EBIT Growth	27.44%	20.70%	-5.79%	-26.40%	-14.65%	-1.46%	17.88%	17.55%	32.28%	25.16%
NOPAT Growth	25.97%	19.99%	-4.96%	-12.06%	-16.76%	2.11%	26.56%	12.51%	39.26%	23.44%
Net Income Growth	26.19%	20.06%	-6.24%	-10.12%	-18.08%	1.72%	26.63%	16.73%	36.92%	23.67%
EPS Growth	29.63%	22.86%	-2.33%	-5.95%	-16.46%	3.03%	26.47%	18.02%	38.92%	24.47%
Operating Cash Flow Growth	27.60%	15.97%	17.74%	-16.28%	6.96%	-4.10%	31.44%	-3.00%	37.07%	19.81%
Free Cash Flow Firm Growth	28.91%	24.22%	21.74%	-25.17%	-4.83%	4.21%	31.54%	-20.16%	51.84%	12.86%
Invested Capital Growth	15.88%	10.52%	-32.97%	-5.77%	-32.16%	-55.09%	-192.04%	110.24%	463.72%	336.46%
Revenue Q/Q Growth	2.02%	1.03%	-0.59%	0.05%	1.41%	-0.99%	3.82%	3.59%	4.52%	0.00%
EBITDA Q/Q Growth	6.34%	3.25%	-1.47%	-6.33%	-6.01%	2.66%	-0.68%	12.18%	4.64%	0.00%
EBIT Q/Q Growth	6.40%	3.31%	-1.50%	-6.57%	-6.61%	2.99%	-0.45%	12.98%	4.77%	0.00%
NOPAT Q/Q Growth	6.71%	2.84%	-3.92%	1.47%	-10.15%	4.94%	-0.27%	15.12%	6.67%	0.00%
Net Income Q/Q Growth	6.17%	2.94%	-4.43%	1.36%	-9.65%	4.53%	0.04%	15.48%	6.56%	0.00%
EPS Q/Q Growth	5.26%	1.78%	-2.89%	2.60%	-9.59%	4.62%	0.00%	15.34%	7.22%	0.00%
Operating Cash Flow Q/Q Growth	-3.48%	1.26%	6.20%	-8.89%	0.36%	2.51%	1.14%	9.19%	15.55%	0.00%
Free Cash Flow Firm Q/Q Growth	-4.54%	1.19%	5.98%	-12.07%	-2.37%	5.24%	-1.84%	10.93%	23.09%	636.09%
Invested Capital Q/Q Growth	-6.30%	-3.22%	-23.52%	1.75%	-16.91%	-34.67%	-67.08%	23.91%	-72.88%	-47.78%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	57.69%	58.67%	58.67%	56.92%	53.89%	100.00%	55.12%	53.30%	53.63%	54.82%
EBITDA Margin	30.42%	33.75%	32.41%	25.71%	19.96%	20.91%	21.38%	21.40%	23.06%	25.62%
Operating Margin	29.02%	32.14%	31.22%	23.94%	18.76%	19.45%	20.24%	19.91%	22.60%	25.10%
EBIT Margin	29.03%	32.25%	30.89%	24.17%	18.67%	19.39%	20.19%	20.54%	22.44%	25.02%
Profit (Net Income) Margin	18.60%	20.55%	19.59%	18.72%	13.88%	14.88%	16.65%	16.81%	19.01%	20.95%
Tax Burden Percent	63.54%	63.35%	63.02%	76.85%	73.88%	76.68%	82.40%	81.56%	82.64%	81.84%
Interest Burden Percent	100.82%	100.60%	100.64%	100.79%	100.62%	100.09%	100.05%	100.38%	102.55%	102.31%
Effective Tax Rate	36.46%	36.65%	36.98%	23.15%	26.12%	23.32%	17.60%	18.44%	17.36%	18.16%
Return on Invested Capital (ROIC)	165.04%	175.24%	189.95%	214.32%	219.10%	381.98%	19,590.63%	0.00%	3,908.86%	1,059.00%
ROIC Less NNEP Spread (ROIC-NNEP)	164.34%	174.23%	190.41%	212.72%	219.00%	382.12%	19,590.72%	0.00%	3,907.60%	1,057.41%
Return on Net Nonoperating Assets (RNNOA)	-110.22%	-107.14%	-122.29%	-149.31%	-159.84%	-333.67%	-19,543.57%	0.00%	-3,838.94%	-983.37%
Return on Equity (ROE)	54.82%	68.10%	67.66%	65.00%	59.26%	48.31%	47.06%	54.02%	69.92%	75.64%
Cash Return on Invested Capital (CROIC)	150.33%	165.25%	229.43%	220.26%	257.43%	458.01%	0.00%	8,237.76%	3,769.13%	933.57%
Operating Return on Assets (OROA)	49.66%	61.95%	60.01%	43.45%	33.96%	27.14%	26.66%	28.39%	33.51%	36.45%
Return on Assets (ROA)	31.82%	39.48%	38.06%	33.65%	25.25%	20.83%	21.98%	23.24%	28.40%	30.52%
Return on Common Equity (ROCE)	54.82%	68.10%	67.66%	65.00%	59.26%	48.31%	47.06%	54.02%	69.92%	75.64%
Return on Equity Simple (ROE_SIMPLE)	52.93%	73.35%	66.58%	71.15%	60.28%	39.85%	44.08%	56.86%	63.45%	73.00%
Net Operating Profit after Tax (NOPAT)	103	123	117	103	86	87	111	125	173	214
NOPAT Margin	18.44%	20.36%	19.68%	18.40%	13.86%	14.92%	16.68%	16.24%	18.67%	20.54%
Net Nonoperating Expense Percent (NNEP)	0.70%	1.02%	-0.46%	1.59%	0.11%	-0.14%	-0.09%	1.81%	1.26%	1.59%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	54.91%	62.32%	71.57%
Cost of Revenue to Revenue	42.31%	41.33%	41.33%	43.08%	46.12%	0.00%	44.88%	46.70%	46.37%	45.18%
SG&A Expenses to Revenue	8.85%	7.99%	7.75%	0.00%	10.45%	10.48%	10.26%	9.53%	8.74%	8.62%
R&D to Revenue	9.68%	9.05%	9.70%	12.86%	14.18%	14.37%	14.71%	14.58%	13.65%	13.21%
Operating Expenses to Revenue	28.67%	26.53%	27.45%	32.98%	35.13%	80.55%	34.88%	33.39%	31.04%	29.72%
Earnings before Interest and Taxes (EBIT)	162	195	184	135	115	114	134	158	208	261
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	169	204	193	144	123	123	142	164	214	267
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	24.73	22.29	19.52	18.83	35.82	30.52	39.26	33.40	47.64	55.18
Price to Tangible Book Value (P/TBV)	36.28	35.24	30.30	32.62	63.67	42.66	52.23	46.03	61.36	69.67
Price to Revenue (P/Rev)	8.69	6.24	5.74	4.95	8.25	11.40	14.83	9.88	14.27	15.83
Price to Earnings (P/E)	46.72	30.39	29.32	26.46	59.42	76.59	89.07	58.74	75.08	75.58
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.14%	3.29%	3.41%	3.78%	1.68%	1.31%	1.12%	1.70%	1.33%	1.32%
Enterprise Value to Invested Capital (EV/IC)	70.52	49.89	66.54	57.31	157.77	456.38	0.00	5,497.02	1,722.90	493.64
Enterprise Value to Revenue (EV/Rev)	8.46	6.09	5.53	4.77	8.07	11.05	14.43	9.58	13.98	15.58
Enterprise Value to EBITDA (EV/EBITDA)	27.80	18.03	17.07	18.57	40.42	52.82	67.48	44.76	60.65	60.80
Enterprise Value to EBIT (EV/EBIT)	29.14	18.87	17.91	19.75	43.22	56.98	71.46	46.66	62.32	62.27
Enterprise Value to NOPAT (EV/NOPAT)	45.87	29.89	28.12	25.95	58.21	74.06	86.51	59.01	74.87	75.85
Enterprise Value to Operating Cash Flow (EV/OCF)	39.17	26.41	20.05	19.44	33.94	45.97	51.71	40.91	52.74	55.05
Enterprise Value to Free Cash Flow (EV/FCFF)	50.36	31.70	23.28	25.25	49.54	61.76	69.42	66.73	77.65	86.04
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.67	-0.62	-0.64	-0.70	-0.73	-0.87	-1.00	-1.02	-0.98	-0.93
Leverage Ratio	1.72	1.73	1.78	1.93	2.35	2.32	2.14	2.32	2.46	2.48
Compound Leverage Factor	1.74	1.74	1.79	1.95	2.36	2.32	2.14	2.33	2.52	2.54
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	25.76	23.16	19.67	14.68	16.74	19.39	23.53	16.33	23.37	24.89
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.86	1.76	1.84	1.48	1.28	1.70	1.64	1.32	1.31	1.26
Quick Ratio	1.78	1.67	1.75	1.38	1.17	1.59	1.56	1.24	1.24	1.18
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	93	116	141	106	101	105	138	110	167	189
Operating Cash Flow to CapEx	1,045.54%	2,036.33%	2,646.65%	1,879.95%	966.95%	5,160.62%	4,611.13%	2,727.04%	5,205.45%	3,400.61%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.71	1.92	1.94	1.80	1.82	1.40	1.32	1.38	1.49	1.46
Accounts Receivable Turnover	6.04	6.12	6.18	5.81	6.15	5.58	5.68	5.27	5.34	5.39
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	28.95	31.32	36.13	37.51	33.36	28.87	41.75	57.48	75.51	80.91
Accounts Payable Turnover	19.87	21.48	18.84	14.96	14.71	0.00	15.91	15.81	17.15	18.43
Days Sales Outstanding (DSO)	60.42	59.67	59.09	62.78	59.38	65.40	64.25	69.28	68.37	67.70
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	18.37	17.00	19.37	24.40	24.81	0.00	22.94	23.09	21.28	19.81
Cash Conversion Cycle (CCC)	42.05	42.67	39.72	38.37	34.56	65.40	41.31	46.19	47.09	47.89
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	67	74	49	47	32	14	-13	1.34	7.54	33
Invested Capital Turnover	8.95	8.61	9.65	11.65	15.81	25.61	1,174.59	-130.85	209.31	51.56
Increase / (Decrease) in Invested Capital	9.15	7.02	-24	-2.85	-15	-17	-27	14	6.20	25
Enterprise Value (EV)	4,706	3,680	3,289	2,670	4,985	6,477	9,576	7,350	12,985	16,239
Market Capitalization	4,835	3,775	3,415	2,770	5,096	6,682	9,840	7,575	13,256	16,505
Book Value per Share	$2.68	$2.38	$2.54	$2.25	$2.23	$3.45	$3.96	$3.63	$4.52	$4.90
Tangible Book Value per Share	$1.82	$1.51	$1.64	$1.30	$1.25	$2.47	$2.98	$2.64	$3.51	$3.88
Total Capital	195	169	175	147	142	219	251	227	278	299
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-129	-96	-126	-101	-111	-205	-264	-225	-271	-266
Capital Expenditures (CapEx)	11	6.84	6.20	7.31	15	2.73	4.02	6.59	4.73	8.68
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-19	-6.24	-22	-30	-60	-68	-104	-126	-157	-163
Debt-free Net Working Capital (DFNWC)	110	89	104	70	50	137	159	100	113	103
Net Working Capital (NWC)	110	89	104	70	50	137	159	100	113	103
Net Nonoperating Expense (NNE)	-0.89	-1.14	0.51	-1.80	-0.11	0.22	0.22	-4.42	-3.13	-4.27
Net Nonoperating Obligations (NNO)	-129	-96	-126	-101	-111	-205	-264	-225	-271	-266
Total Depreciation and Amortization (D&A)	7.76	9.09	9.06	8.61	7.99	8.95	7.91	6.66	5.75	6.30
Debt-free, Cash-free Net Working Capital to Revenue	-3.42%	-1.03%	-3.65%	-5.45%	-9.75%	-11.54%	-15.72%	-16.38%	-16.96%	-15.66%
Debt-free Net Working Capital to Revenue	19.72%	14.78%	17.46%	12.54%	8.16%	23.37%	24.02%	13.01%	12.20%	9.88%
Net Working Capital to Revenue	19.72%	14.78%	17.46%	12.54%	8.16%	23.37%	24.02%	13.01%	12.20%	9.88%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.41	$1.73	$1.68	$1.58	$1.33	$1.37	$1.74	$2.05	$0.00	$3.56
Adjusted Weighted Average Basic Shares Outstanding	73.44M	71.67M	69.18M	66.20M	64.40M	63.54M	63.45M	62.77M	0.00	61.30M
Adjusted Diluted Earnings per Share	$1.40	$1.72	$1.68	$1.58	$1.32	$1.36	$1.72	$2.03	$0.00	$3.51
Adjusted Weighted Average Diluted Shares Outstanding	74.04M	72.06M	69.42M	66.43M	65.10M	64.33M	64.32M	63.41M	0.00	62.18M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	73.00M	70.40M	67.97M	65.02M	63.77M	63.80M	63.15M	62.50M	0.00	61.12M
Normalized Net Operating Profit after Tax (NOPAT)	103	123	119	103	86	87	111	125	173	214
Normalized NOPAT Margin	18.44%	20.36%	19.99%	18.40%	13.86%	14.92%	16.68%	16.24%	18.67%	20.54%
Pre Tax Income Margin	29.27%	32.44%	31.09%	24.36%	18.78%	19.40%	20.20%	20.61%	23.01%	25.60%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	108.37%	135.17%	113.07%	142.63%	141.66%	49.93%	109.00%	158.55%	111.03%	131.14%

This table displays calculated financial ratios and metrics derived from Manhattan Associates' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	17.09%	15.52%	23.50%	20.37%	20.36%	20.27%	15.18%	14.85%	11.84%	7.36%	3.24%
EBITDA Growth	-9.57%	62.27%	33.62%	28.13%	41.40%	20.43%	23.41%	33.58%	37.90%	4.21%	9.87%
EBIT Growth	-9.40%	67.41%	36.06%	30.45%	43.78%	21.12%	24.13%	34.12%	38.44%	4.09%	10.03%
NOPAT Growth	-22.52%	79.10%	29.16%	33.52%	68.37%	29.18%	36.75%	34.13%	30.97%	-3.21%	-2.64%
Net Income Growth	-19.04%	83.99%	26.80%	28.53%	66.55%	28.70%	38.69%	33.18%	29.06%	-1.48%	-2.27%
EPS Growth	-17.54%	84.38%	29.17%	28.57%	68.09%	32.20%	38.71%	34.92%	30.38%	-1.28%	-1.16%
Operating Cash Flow Growth	-33.12%	37.72%	84.69%	-23.00%	46.73%	59.99%	-6.78%	80.58%	6.36%	18.50%	37.49%
Free Cash Flow Firm Growth	-70.51%	-52.55%	9.28%	93.95%	8.29%	83.62%	-49.32%	-11.44%	29.93%	-49.49%	118.69%
Invested Capital Growth	113.80%	110.24%	-163.86%	24.16%	2,475.81%	463.72%	6,234.42%	119.75%	126.67%	336.46%	22.25%
Revenue Q/Q Growth	3.22%	0.00%	11.56%	4.53%	3.21%	-0.08%	0.00%	4.23%	0.51%	-4.08%	2.73%
EBITDA Q/Q Growth	-2.90%	15.97%	4.89%	8.48%	7.16%	-1.23%	0.00%	17.42%	10.62%	-25.36%	13.32%
EBIT Q/Q Growth	-2.82%	17.08%	5.10%	9.10%	7.11%	-1.38%	0.00%	17.87%	10.56%	-25.85%	13.86%
NOPAT Q/Q Growth	-2.22%	30.79%	4.02%	0.38%	23.30%	0.34%	0.00%	-1.55%	20.39%	-25.84%	10.77%
Net Income Q/Q Growth	-3.73%	27.61%	2.44%	2.14%	24.74%	-1.39%	0.00%	-1.92%	20.88%	-24.72%	9.51%
EPS Q/Q Growth	-4.08%	25.53%	5.08%	1.61%	25.40%	-1.27%	0.00%	-1.16%	21.18%	-25.24%	10.39%
Operating Cash Flow Q/Q Growth	-24.24%	38.35%	6.32%	-30.90%	44.38%	50.85%	0.00%	33.84%	-14.96%	68.07%	-28.12%
Free Cash Flow Firm Q/Q Growth	6.82%	16.64%	75.66%	-11.38%	-40.36%	97.77%	0.00%	54.85%	-12.50%	-23.11%	109.93%
Invested Capital Q/Q Growth	-92.24%	23.91%	-139.12%	3,399.43%	61.06%	-72.88%	0.00%	18.19%	66.14%	-47.78%	19.23%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	51.46%	54.57%	53.11%	52.90%	53.26%	55.20%	100.00%	54.76%	55.50%	9.20%	56.40%
EBITDA Margin	20.21%	23.44%	22.04%	22.87%	23.75%	23.48%	23.62%	26.61%	29.28%	22.79%	25.13%
Operating Margin	18.56%	22.57%	21.30%	21.85%	22.42%	24.71%	22.64%	25.70%	28.16%	23.72%	24.04%
EBIT Margin	19.38%	22.68%	21.37%	22.30%	23.14%	22.84%	23.03%	26.05%	28.65%	22.15%	24.55%
Profit (Net Income) Margin	14.98%	19.12%	17.55%	17.15%	20.73%	20.46%	21.14%	19.89%	23.92%	18.77%	20.01%
Tax Burden Percent	77.31%	83.17%	82.14%	76.90%	89.55%	81.59%	91.77%	76.36%	83.48%	76.60%	81.51%
Interest Burden Percent	100.00%	101.33%	100.00%	100.00%	100.00%	109.75%	100.00%	100.00%	100.00%	110.64%	100.00%
Effective Tax Rate	22.69%	16.83%	17.86%	23.10%	10.45%	18.41%	8.23%	23.64%	16.52%	23.40%	18.49%
Return on Invested Capital (ROIC)	0.00%	0.00%	95,666.23%	915.04%	1,235.58%	4,219.45%	0.00%	0.00%	0.00%	937.00%	577.40%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	95,666.17%	914.58%	1,234.76%	4,219.16%	0.00%	0.00%	0.00%	936.43%	576.88%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	-95,595.06%	-839.46%	-1,147.43%	-4,145.03%	0.00%	0.00%	0.00%	-870.85%	-492.01%
Return on Equity (ROE)	51.14%	54.02%	71.17%	75.58%	88.15%	74.41%	0.00%	0.00%	0.00%	66.14%	85.39%
Cash Return on Invested Capital (CROIC)	9,201.57%	8,237.76%	0.00%	896.83%	941.19%	3,769.13%	-101.63%	-74.90%	-77.55%	933.57%	576.62%
Operating Return on Assets (OROA)	27.88%	31.36%	33.17%	36.34%	37.82%	34.12%	0.00%	0.00%	0.00%	32.27%	37.30%
Return on Assets (ROA)	21.56%	26.42%	27.24%	27.94%	33.86%	30.55%	0.00%	0.00%	0.00%	27.35%	30.40%
Return on Common Equity (ROCE)	51.14%	54.02%	71.17%	75.58%	88.15%	74.41%	0.00%	0.00%	0.00%	66.14%	85.39%
Return on Equity Simple (ROE_SIMPLE)	56.36%	0.00%	75.75%	85.58%	78.87%	0.00%	0.00%	0.00%	0.00%	0.00%	88.60%
Net Operating Profit after Tax (NOPAT)	28	37	39	39	48	48	53	52	63	46	51
NOPAT Margin	14.35%	18.77%	17.50%	16.80%	20.07%	20.16%	20.78%	19.62%	23.51%	18.17%	19.59%
Net Nonoperating Expense Percent (NNEP)	0.56%	0.28%	0.06%	0.46%	0.82%	0.29%	0.47%	0.39%	0.55%	0.57%	0.53%
Return On Investment Capital (ROIC_SIMPLE)	-	16.39%	-	-	-	17.26%	-	-	-	15.54%	21.01%
Cost of Revenue to Revenue	48.54%	45.43%	46.89%	47.10%	46.74%	44.80%	0.00%	45.24%	44.50%	90.80%	43.60%
SG&A Expenses to Revenue	9.28%	9.14%	9.03%	8.76%	8.96%	8.23%	8.33%	7.96%	7.62%	10.63%	9.22%
R&D to Revenue	14.83%	13.69%	13.93%	13.68%	13.88%	13.15%	13.75%	13.32%	12.88%	12.90%	13.43%
Operating Expenses to Revenue	32.90%	32.00%	31.81%	31.05%	30.85%	30.50%	77.36%	29.06%	27.35%	-14.53%	32.36%
Earnings before Interest and Taxes (EBIT)	38	45	47	52	55	54	59	69	76	57	65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	40	46	49	53	57	56	60	71	78	58	66
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	42.11	33.40	53.45	72.69	58.02	47.64	64.29	63.12	62.00	55.18	43.15
Price to Tangible Book Value (P/TBV)	61.39	46.03	81.43	114.46	82.43	61.36	86.85	85.14	79.89	69.67	57.84
Price to Revenue (P/Rev)	11.27	9.88	11.96	14.62	13.72	14.27	0.00	0.00	0.00	15.83	10.07
Price to Earnings (P/E)	74.71	58.74	70.56	84.95	73.56	75.08	0.00	0.00	0.00	75.58	48.71
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.34%	1.70%	1.42%	1.18%	1.36%	1.33%	0.00%	0.00%	0.00%	1.32%	2.05%
Enterprise Value to Invested Capital (EV/IC)	7,549.97	5,497.02	0.00	709.59	432.02	1,722.90	473.71	395.18	270.14	493.64	264.42
Enterprise Value to Revenue (EV/Rev)	11.00	9.58	11.74	14.44	13.51	13.98	0.00	0.00	0.00	15.58	9.87
Enterprise Value to EBITDA (EV/EBITDA)	55.66	44.76	53.82	65.12	58.68	60.65	0.00	0.00	0.00	60.80	37.99
Enterprise Value to EBIT (EV/EBIT)	58.43	46.66	55.84	67.25	60.38	62.32	0.00	0.00	0.00	62.27	38.89
Enterprise Value to NOPAT (EV/NOPAT)	75.30	59.01	71.25	85.59	73.85	74.87	0.00	0.00	0.00	75.85	48.75
Enterprise Value to Operating Cash Flow (EV/OCF)	49.52	40.91	45.97	62.98	56.35	52.74	0.00	0.00	0.00	55.05	32.87
Enterprise Value to Free Cash Flow (EV/FCFF)	82.05	66.73	70.54	87.65	88.37	77.65	0.00	0.00	0.00	86.04	50.45
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-1.02	-1.02	-1.00	-0.92	-0.93	-0.98	-0.93	-0.87	-0.81	-0.93	-0.85
Leverage Ratio	2.36	2.32	2.62	2.75	2.66	2.46	2.87	2.90	2.60	2.48	2.85
Compound Leverage Factor	2.36	2.36	2.62	2.75	2.66	2.70	2.87	2.90	2.60	2.74	2.85
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	18.31	15.67	19.08	23.39	22.73	22.61	22.21	22.48	25.73	24.00	16.11
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.29	1.32	1.15	1.09	1.18	1.31	1.20	1.17	1.25	1.26	1.12
Quick Ratio	1.20	1.24	1.06	1.00	1.10	1.24	1.11	1.09	1.14	1.18	1.03
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	20	23	40	35	21	42	20	31	27	21	44
Operating Cash Flow to CapEx	2,091.15%	2,268.09%	8,816.22%	4,020.81%	5,393.46%	4,487.51%	2,358.38%	3,304.56%	6,174.33%	3,347.31%	8,446.69%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.44	1.38	1.55	1.63	1.63	1.49	0.00	0.00	0.00	1.46	1.52
Accounts Receivable Turnover	5.72	5.27	5.53	5.43	5.44	5.34	0.00	0.00	0.00	5.39	5.05
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	55.81	57.48	64.05	70.40	75.52	75.51	0.00	0.00	0.00	80.91	80.22
Accounts Payable Turnover	14.28	15.81	0.81	1.57	2.12	17.15	0.00	0.00	0.00	18.43	18.43
Days Sales Outstanding (DSO)	63.80	69.28	66.00	67.19	67.14	68.37	0.00	0.00	0.00	67.70	72.33
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	25.56	23.09	451.17	231.82	172.54	21.28	0.00	0.00	0.00	19.81	19.81
Cash Conversion Cycle (CCC)	38.23	46.19	-385.18	-164.62	-105.40	47.09	0.00	0.00	0.00	47.89	52.53
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1.08	1.34	-0.52	17	28	7.54	32	38	63	33	39
Invested Capital Turnover	-219.76	-130.85	5,467.17	54.45	61.55	209.31	0.00	0.00	0.00	51.56	29.47
Increase / (Decrease) in Invested Capital	8.90	14	-1.34	3.36	27	6.20	33	21	35	25	7.14
Enterprise Value (EV)	8,146	7,350	9,496	12,245	12,007	12,985	15,198	14,985	17,018	16,239	10,371
Market Capitalization	8,343	7,575	9,678	12,398	12,189	13,256	15,405	15,188	17,233	16,505	10,577
Book Value per Share	$3.16	$3.63	$2.90	$2.75	$3.41	$4.52	$3.89	$3.91	$4.54	$4.90	$4.01
Tangible Book Value per Share	$2.17	$2.64	$1.90	$1.75	$2.40	$3.51	$2.88	$2.90	$3.52	$3.88	$2.99
Total Capital	198	227	181	171	210	278	240	241	278	299	245
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-197	-225	-182	-153	-182	-271	-208	-203	-215	-266	-206
Capital Expenditures (CapEx)	1.91	2.44	0.67	1.01	1.09	1.97	2.32	2.22	1.01	3.13	0.89
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-114	-126	-133	-124	-122	-157	-134	-139	-125	-163	-156
Debt-free Net Working Capital (DFNWC)	83	100	49	29	60	113	73	63	90	103	50
Net Working Capital (NWC)	83	100	49	29	60	113	73	63	90	103	50
Net Nonoperating Expense (NNE)	-1.25	-0.69	-0.12	-0.80	-1.56	-0.71	-0.91	-0.70	-1.10	-1.53	-1.09
Net Nonoperating Obligations (NNO)	-197	-225	-182	-153	-182	-271	-208	-203	-215	-266	-206
Total Depreciation and Amortization (D&A)	1.66	1.51	1.49	1.32	1.44	1.51	1.49	1.49	1.69	1.63	1.54
Debt-free, Cash-free Net Working Capital to Revenue	-15.44%	-16.38%	-16.42%	-14.60%	-13.76%	-16.96%	0.00%	0.00%	0.00%	-15.66%	-14.81%
Debt-free Net Working Capital to Revenue	11.17%	13.01%	6.03%	3.47%	6.76%	12.20%	0.00%	0.00%	0.00%	9.88%	4.79%
Net Working Capital to Revenue	11.17%	13.01%	6.03%	3.47%	6.76%	12.20%	0.00%	0.00%	0.00%	9.88%	4.79%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.47	$0.61	$0.62	$0.64	$0.80	$0.80	$0.87	$0.86	$1.04	$0.79	$0.86
Adjusted Weighted Average Basic Shares Outstanding	62.59M	62.77M	62.21M	61.86M	61.64M	61.82M	61.63M	61.42M	61.17M	61.30M	60.87M
Adjusted Diluted Earnings per Share	$0.47	$0.59	$0.62	$0.63	$0.79	$0.78	$0.86	$0.85	$1.03	$0.77	$0.85
Adjusted Weighted Average Diluted Shares Outstanding	63.17M	63.41M	62.77M	62.43M	62.31M	62.61M	62.49M	62.12M	61.95M	62.18M	61.53M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	62.40M	62.50M	62.03M	61.67M	61.57M	0.00	61.57M	61.25M	61.08M	61.12M	60.71M
Normalized Net Operating Profit after Tax (NOPAT)	28	37	39	39	48	48	53	52	63	46	54
Normalized NOPAT Margin	14.35%	18.77%	17.50%	16.80%	20.07%	20.16%	20.78%	19.62%	23.51%	18.17%	20.50%
Pre Tax Income Margin	19.38%	22.98%	21.37%	22.30%	23.14%	25.07%	23.03%	26.05%	28.65%	24.51%	24.55%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	178.38%	158.55%	166.99%	168.40%	133.46%	111.03%	0.00%	0.00%	0.00%	131.14%	142.29%

Frequently Asked Questions About Manhattan Associates' Financials

When does Manhattan Associates's financial year end?

According to the most recent income statement we have on file, Manhattan Associates' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Manhattan Associates' net income changed over the last 9 years?

Manhattan Associates' net income appears to be on an upward trend, with a most recent value of $218.36 million in 2024, rising from $103.48 million in 2015. The previous period was $176.57 million in 2023. Check out Manhattan Associates' forecast to explore projected trends and price targets.

What is Manhattan Associates's operating income?

Manhattan Associates's total operating income in 2024 was $261.60 million, based on the following breakdown:

Total Gross Profit: $571.37 million
Total Operating Expenses: $309.78 million

How has Manhattan Associates revenue changed over the last 9 years?

Over the last 9 years, Manhattan Associates' total revenue changed from $556.37 million in 2015 to $1.04 billion in 2024, a change of 87.3%.

How much debt does Manhattan Associates have?

Manhattan Associates' total liabilities were at $458.43 million at the end of 2024, a 16.0% increase from 2023, and a 235.2% increase since 2015.

How much cash does Manhattan Associates have?

In the past 9 years, Manhattan Associates' cash and equivalents has ranged from $95.62 million in 2016 to $270.74 million in 2023, and is currently $266.23 million as of their latest financial filing in 2024.

How has Manhattan Associates' book value per share changed over the last 9 years?

Over the last 9 years, Manhattan Associates' book value per share changed from 2.68 in 2015 to 4.90 in 2024, a change of 83.1%.

Related Companies

This page (NASDAQ:MANH) was last updated on 5/4/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Manhattan Associates (MANH) Financials

Frequently Asked Questions About Manhattan Associates' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Manhattan Associates (MANH) Financials

Annual Income Statements for Manhattan Associates

Quarterly Income Statements for Manhattan Associates

Annual Cash Flow Statements for Manhattan Associates

Quarterly Cash Flow Statements for Manhattan Associates

Annual Balance Sheets for Manhattan Associates

Quarterly Balance Sheets for Manhattan Associates

Annual Metrics and Ratios for Manhattan Associates

Quarterly Metrics and Ratios for Manhattan Associates

Frequently Asked Questions About Manhattan Associates' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools